181 related articles for article (PubMed ID: 37950809)
21. Causal association between autoimmune liver disease and Sjögren's syndrome: A Mendelian randomization study.
Li Y; Wang J; Jiang H; Zhang J; Qi J; Jiang Z; Chen L; Ying Z
Int J Rheum Dis; 2024 May; 27(5):e15151. PubMed ID: 38720573
[TBL] [Abstract][Full Text] [Related]
22.
Zecher BF; Ellinghaus D; Schloer S; Niehrs A; Padoan B; Baumdick ME; Yuki Y; Martin MP; Glow D; Schröder-Schwarz J; Niersch J; Brias S; Müller LM; Habermann R; Kretschmer P; Früh T; Dänekas J; Wehmeyer MH; Poch T; Sebode M; ; Ellinghaus E; Degenhardt F; Körner C; Hoelzemer A; Fehse B; Oldhafer KJ; Schumacher U; Sauter G; Carrington M; Franke A; Bunders MJ; Schramm C; Altfeld M
Gut; 2024 Jan; 73(2):325-337. PubMed ID: 37788895
[TBL] [Abstract][Full Text] [Related]
23. Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis.
Eksteen B
Br Med Bull; 2014 Jun; 110(1):89-98. PubMed ID: 24795363
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis.
Donaldson PT; Norris S
Autoimmunity; 2002 Dec; 35(8):555-64. PubMed ID: 12765483
[TBL] [Abstract][Full Text] [Related]
25. Proteome-Wide Mendelian Randomization Analysis Identified Potential Drug Targets for Atrial Fibrillation.
Wang X; Huang T; Jia J
J Am Heart Assoc; 2023 Aug; 12(16):e029003. PubMed ID: 37581400
[TBL] [Abstract][Full Text] [Related]
26. Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.
Naess S; Björnsson E; Anmarkrud JA; Al Mamari S; Juran BD; Lazaridis KN; Chapman R; Bergquist A; Melum E; Marsh SG; Schrumpf E; Lie BA; Boberg KM; Karlsen TH; Hov JR
Liver Int; 2014 Nov; 34(10):1488-95. PubMed ID: 24517468
[TBL] [Abstract][Full Text] [Related]
27. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
28. Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.
Næss S; Lie BA; Melum E; Olsson M; Hov JR; Croucher PJ; Hampe J; Thorsby E; Bergquist A; Traherne JA; Schrumpf E; Boberg KM; Schreiber S; Franke A; Karlsen TH
PLoS One; 2014; 9(12):e114486. PubMed ID: 25521205
[TBL] [Abstract][Full Text] [Related]
29. Causal Linkage Between Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Two-Sample Mendelian Randomization Analysis.
Xie Y; Chen X; Deng M; Sun Y; Wang X; Chen J; Yuan C; Hesketh T
Front Genet; 2021; 12():649376. PubMed ID: 33815483
[TBL] [Abstract][Full Text] [Related]
30. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.
Olerup O; Olsson R; Hultcrantz R; Broome U
Gastroenterology; 1995 Mar; 108(3):870-8. PubMed ID: 7875491
[TBL] [Abstract][Full Text] [Related]
31. Primary sclerosing cholangitis in two brothers: report of a family with special emphasis on molecular HLA and MICA genotyping.
Van Steenbergen W; De Goede E; Emonds MP; Reinders J; Tilanus M; Fevery J
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):767-71. PubMed ID: 15947556
[TBL] [Abstract][Full Text] [Related]
32. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.
Zhang Y; Liu W; Lai J; Zeng H
Front Immunol; 2024; 15():1394438. PubMed ID: 38835753
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.
Zhang W; Ma L; Zhou Q; Gu T; Zhang X; Xing H
Diabetes; 2024 Apr; 73(4):618-627. PubMed ID: 38211557
[TBL] [Abstract][Full Text] [Related]
34. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
Hov JR; Lleo A; Selmi C; Woldseth B; Fabris L; Strazzabosco M; Karlsen TH; Invernizzi P
J Hepatol; 2010 May; 52(5):712-7. PubMed ID: 20347497
[TBL] [Abstract][Full Text] [Related]
35. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases.
Zheng J; Haberland V; Baird D; Walker V; Haycock PC; Hurle MR; Gutteridge A; Erola P; Liu Y; Luo S; Robinson J; Richardson TG; Staley JR; Elsworth B; Burgess S; Sun BB; Danesh J; Runz H; Maranville JC; Martin HM; Yarmolinsky J; Laurin C; Holmes MV; Liu JZ; Estrada K; Santos R; McCarthy L; Waterworth D; Nelson MR; Smith GD; Butterworth AS; Hemani G; Scott RA; Gaunt TR
Nat Genet; 2020 Oct; 52(10):1122-1131. PubMed ID: 32895551
[TBL] [Abstract][Full Text] [Related]
36. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
37. Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses.
Cao M; Cui B
Cardiovasc Diabetol; 2024 Apr; 23(1):126. PubMed ID: 38614964
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the acute pathogenesis of spondyloarthritis/HLA-B27-associated anterior uveitis based on genome-wide association analysis and single-cell transcriptomics.
Chen S; Huang W; Wan Q; Tang Z; Li X; Zeng F; Zheng S; Li Z; Liu X
J Transl Med; 2024 Mar; 22(1):271. PubMed ID: 38475831
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
Melum E; Franke A; Schramm C; Weismüller TJ; Gotthardt DN; Offner FA; Juran BD; Laerdahl JK; Labi V; Björnsson E; Weersma RK; Henckaerts L; Teufel A; Rust C; Ellinghaus E; Balschun T; Boberg KM; Ellinghaus D; Bergquist A; Sauer P; Ryu E; Hov JR; Wedemeyer J; Lindkvist B; Wittig M; Porte RJ; Holm K; Gieger C; Wichmann HE; Stokkers P; Ponsioen CY; Runz H; Stiehl A; Wijmenga C; Sterneck M; Vermeire S; Beuers U; Villunger A; Schrumpf E; Lazaridis KN; Manns MP; Schreiber S; Karlsen TH
Nat Genet; 2011 Jan; 43(1):17-9. PubMed ID: 21151127
[TBL] [Abstract][Full Text] [Related]
40. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
